Concepedia

Véronique Damagnez

VD

Statistics

Publications

9

Citations

413

H-Index

9

Active since

1989

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Véronique Damagnez is an author at Vertex Pharmaceuticals (United States) specializing in life sciences, molecular biology, and pharmacology.

Publications per year

1989–2018

9

Publications

9

Pharmacological activation and inhibition of Slack (Slo2.2) channels

Bingwei Yang, Valentin K. Gribkoff, Jianbin Pan et al. · Neuropharmacology · 2006 · 106 citations

Medicine, Pharmacology, Physiology +11

Schizosaccharomyces pombe Mop1‐Mcs2 is related to mammalian CAK.

Véronique Damagnez, Tomi P. Mäkelä, Guillaume Cottarel · The EMBO Journal · 1995 · 85 citations · Full text

Life Sciences, Biology, Molecular Biology +5

The POL1 gene from the fission yeast, Schizosaccharomyces pombe, shows conserved amino acid blocks specific for eukaryotic DNA polymerases alpha

Véronique Damagnez, Jeanne Tillit, Anne-Marie de Recondo et al. · Molecular and General Genetics MGG · 1991 · 58 citations

Life Sciences, Genetics, Molecular Biology +11

Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)

Jon H. Come, Philip N. Collier, James A. Henderson et al. · Journal of Medicinal Chemistry · 2018 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Saturation of mismatch repair in the mutD5 mutator strain of Escherichia coli

Véronique Damagnez, Marie-Pascale Doutriaux, Miroslav Radman · Journal of Bacteriology · 1989 · 45 citations · Full text

Life Sciences, Genetics, Microbiology +17

1–5 of 9